Navigation Links
Biotech Cools Off in August But Capital Markets Remain Positive
Date:9/1/2009

% % 12/31 12/31 6/30 7/31 8/31 change change Index 2007 2008 2009 2009 2009 Month YTD Burrill Biotech 331.52 300.33 294.09 313.23 309.76 -1.11% 3.14% Select Burrill Large Cap Biotech 437.71 379.7 424.71 452.87 450.36 -0.55% 18.61% Burrill Mid-Cap 201.89 139.39 173.97 178.77 176.26 -1.40% 26.45% Burrill Small Cap 137.6 78.35 82.51 96.13 100.56 4.61% 28.35% NASDAQ 2652.28 1577.03 1835.04 1978.5 2009.06 1.54% 27.40% DJIA 13264.82 8776.39 8447 9171.61 9496.28 3.54% 8.20%

About Burrill & Company

Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. Burrill is also the creator, sponsor and facilitator of over a dozen leading industry conferences worldwide and publisher of a range of bio-intelligence reports including the monthly Burrill Report, which tracks the progress of the global biotechnology industry and annual "State of the Industry" report the latest of which is Biotech 2009-Life Sciences: Navigating the Sea Change, the 23rd annual report on the industry. The 470-plus page book contains analysis and perspectives on the performance of the industry in 2008 and projections for 2009 and beyond. (www.burrillandco.com)


'/>"/>
SOURCE Burrill & Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes
2. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
3. Oncolytics Biotech(R) Inc. Announces Issuance of 32nd U.S. Patent
4. SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies
5. Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results
6. Malaysian Biotechnology Sector
7. PCI Biotech Commences Phase I/II Trials of Amphinex(R)
8. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
9. CBI Hosts 5th Annual Pharma/Biotech Enterprise Governance, Risk and Controls Congress
10. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
11. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Martek Biosciences Corporation (Nasdaq: MATK ) today ... fiscal year ended October 31, 2009. Revenues for the ... million in the fourth quarter of fiscal 2008. Net ... for the fourth quarter of fiscal 2009, a 5% ... share, in last year,s fourth quarter. The fourth ...
(Date:12/16/2009)... /PRNewswire/ -- Capitalizing on the continued ... an active venture capital market, leaders from BioCrossroads, ... Fund, Indiana University, Purdue University, the University of ... Suisse today announced the establishment of the INext ... funds. ,, Organized through BioCrossroads, Indiana,s initiative to ...
(Date:12/16/2009)... supplement? InVitria has what scientists have been asking for! Zap-CHO ... the growth and productivity of CHO cells. Developed for scientists ... free, well defined and consistent recombinant CHO supplement. , ... ... 2009 -- Scientists working with CHO cells can now access ...
(Date:12/15/2009)... three Department of Energy (DOE) bio-energy research centers, has ... valuable intellectual property. , ... ... Surety, LLC , the leading provider of ... Joint BioEnergy Institute (JBEI), one of three Department of ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... First Provider of Clinical Documentation Technology, ... ... Spheris has been selected as,the first awarded supplier of medical ... group purchasing organizations.,Under the parties, agreement, Spheris will provide Provista ...
... 2:00 pm ET on November 27, 2007, CAMBRIDGE, ... ) today announced its participation,in the Lazard Capital Markets ... 2007 at the New York Palace Hotel in New ... will be presenting at 2:00 pm ET on Tuesday, ...
... TORONTO, Nov. 20 /PRNewswire-FirstCall/ - ARIUS Research ... developing the next wave of,antibody therapeutics, today ... of Research, will present at the 14th ... Pereira will present on,ARIUS, non-traditional approach to ...
Other Biology Technology:Provista Awards Agreement to Spheris 2Targanta to Present at Lazard Capital Markets Fourth Annual Healthcare Conference 2ARIUS to present at BioNorth Biotechnology and Life Sciences Conference 2
(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... solutions, today announced that SC Magazine, one ... named BIO-key International the 2009 Innovator of ... Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) ... SC Magazine, "Biometric providers have been trying ...
(Date:12/15/2009)... GAINESVILLE, Fla. When treating devastating brain diseases such ... medical bags to find something to help a patient. ... to help the vast majority of patients with ataxia ... and coordination. , University of Florida neurologists are trying ... million Challenge grant from the National Institute of Neurological ...
(Date:12/15/2009)... mammoths and ancient American horses may have been ... years longer than previously thought. After plucking ancient ... team of researchers used cutting-edge techniques to uncover ... samples dated to between 7,600 and 10,500 calendar ... one population of these now-extinct mammals endured longer ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head Product 26 Portfolio Strategy 13965 1PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head Product 26 Portfolio Strategy 13965 2 C O R R E C T I O N Clinical Therapeutics 13962 1 C O R R E C T I O N Clinical Therapeutics 13962 2 C O R R E C T I O N Clinical Therapeutics 13962 3 C O R R E C T I O N Clinical Therapeutics 13962 4 C O R R E C T I O N Clinical Therapeutics 13962 5Kapstone Medical Acquires Exclusive License to New Orthopedic Technology 56715 1Kapstone Medical Acquires Exclusive License to New Orthopedic Technology 56715 2
... release is available in Spanish . , ... has studied the origin of the mutation that causes Fatal Familiar ... is a high rate of carriers of this mutation 50%of ... Fatal Familiar Insomnia (FFI) is one of the diseases considered as ...
... HIGHLIGHTS BREAKTHROUGH RESEARCH IN UNDERSTANDING GENETIC AND SOCIOECONOMIC ... , Although racial and ethnic differences in treatment ... little is understood about the underlying causes and ... intractable problem. The American Association for Cancer Research ...
... An international group of scientists is linking nutrient pollution ... number of harmful algal blooms reported in recent years. When ... cause human respiratory and skin irritations and cause fish or ... edition of the journal Harmful Algae , scientists present ...
Other Biology News:Study on origin of mutation that causes fatal familiar insomnia 2Study on origin of mutation that causes fatal familiar insomnia 3American Association for Cancer Research hosts Science of Health Care Disparities Meeting 2
... are at least 20 structurally and functionally ... TGF-beta superfamily. BMPs were originally identified as ... They are also involved in embryogenesis and ... regulate the growth, differentiation, chemotaxis and apoptosis ...
dynactin 4, mRNA (cDNA clone MGC:3248 IMAGE:3505855), complete cds...
RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP....
One-step, microplate or cuvet, colorimetric, detection range 0.01 g/dL to 5 g/dL. Procedure: 5 min....
Biology Products: